Stem cell therapies without tears
By Editorial,
The New Scientist
| 06. 15. 2007
Expect to hear a familiar refrain over the coming days: "There's no need for embryonic stem cells." It is the likely response of those who oppose any interference with human embryos to the exciting news that adult mouse cells can be reprogrammed to an embryonic state by boosting the activity of just four critical genes (see "From adult to embryo").
There are good reasons to question the campaigners' claims. The trick has yet to be achieved in human cells. Even if that can be done, it will still be necessary to show that the reprogrammed cells have the same ability as embryonic cells to develop into different tissues. But let's assume that all these issues can one day be resolved. Would the need for cells isolated from embryos disappear?
The eventual goal of the latest work is to derive stem cell lines genetically matched to patients, from which to grow replacement cells and tissues. Transferring the nucleus of an adult cell into an egg can send it back to an embryonic state, but how such cloning works remains mysterious. Reprogramming...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...